ASC 718 Stock Based Compensation/IRC 409a Nonqualified Deferred Compensation
Back Office Valuation & Consulting was engaged by a valuation firm to determine the fair market value of a non-controlling, non-marketable interest in an early-stage, publicly traded, biotechnology company. We immediately inserted ourselves into the project team and engaged in conversations with the subject company’s audit firm to ensure the objectives of the team were aligned. We were able to accurately determine the aggregate value of equity and allocated the equity value amongst the classes of equity securities, which included common stock, incentive stock options, and warrants. Back Office Valuation & Consulting is now an integrated member of the team, and routinely assists the valuation firm with the recurring valuation for financial reporting purposes.